← Leaderboards
Millicent O Sullivan
Benaroya Research Inst At Virginia Mason
$3,906,884
Attributed
$6,957,929
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $761.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,957,929 · 8
By mechanism
R01$5,339,067 · 3
R21$848,903 · 2
P20$725,146 · 2
F32$44,813 · 1
Top collaborators
- Kristi L Kiick9 shared
- David J. Margolis9 shared
- Kara Lorraine Spiller5 shared
- Deepthi Alapati2 shared
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignCellsGenesGene DeliveryMediatingTranslationsGene ExpressionGene TransferIn VivoCostBiocompatible MaterialsGrowth Factor GeneFibroblastsHealingRepairedSafetyEnvironmentLinkScaffoldProductionBaseGene TherapyGene ProductCessation Of Life
Grant awards (20)
COATs: Collagen-mimetic peptide and therapeutic gene-modified collagens for cell-mediated healing of diabetic foot ulcers$563,758
R01 · FY2025 · DK · contact PI
COATs: Collagen-mimetic peptide and therapeutic gene-modified collagens for cell-mediated healing of diabetic foot ulcers$541,208
R01 · FY2024 · DK · contact PI
COATs: Collagen-mimetic peptide and therapeutic gene-modified collagens for cell-mediated healing of diabetic foot ulcers$540,842
R01 · FY2023 · DK · contact PI
Lung selective CRISPR delivery for treatment of genetic surfactant disease$220,505
R21 · FY2023 · HL
COATs: Collagen-mimetic peptide and therapeutic gene-modified collagens for cell-mediated healing of diabetic foot ulcers$456,592
R01 · FY2022 · DK · contact PI
Lung selective CRISPR delivery for treatment of genetic surfactant disease$195,565
R21 · FY2022 · HL
COATs: Collagen-mimetic peptide and therapeutic gene-modified collagens for cell-mediated healing of diabetic foot ulcers$472,220
R01 · FY2021 · DK · contact PI
Suppressing Radiotherapy-Induced Metastasis in Aggressive Breast Cancers via 'On-Demand' siRNA Delivery from Responsive Polymer Nanoparticles$235,766
R21 · FY2020 · EB · contact PI
Collagen turnover-stimulated gene delivery to enhance chronic wound repair$343,951
R01 · FY2019 · AR · contact PI
Suppressing Radiotherapy-Induced Metastasis in Aggressive Breast Cancers via 'On-Demand' siRNA Delivery from Responsive Polymer Nanoparticles$197,067
R21 · FY2019 · EB · contact PI
Collagen turnover-stimulated gene delivery to enhance chronic wound repair$343,622
R01 · FY2018 · AR · contact PI
Histone targeted non-viral gene delivery to enhance bone repair$349,848
R01 · FY2017 · EB · contact PI
Collagen turnover-stimulated gene delivery to enhance chronic wound repair$344,097
R01 · FY2017 · AR · contact PI
Histone targeted non-viral gene delivery to enhance bone repair$350,055
R01 · FY2016 · EB · contact PI
Collagen turnover-stimulated gene delivery to enhance chronic wound repair$336,397
R01 · FY2016 · AR · contact PI
Histone targeted non-viral gene delivery to enhance bone repair$343,512
R01 · FY2015 · EB · contact PI
Histone targeted non-viral gene delivery to enhance bone repair$352,965
R01 · FY2014 · EB · contact PI
SYNTHESIS & ASSEMBLY OF BIO-RESPONSIVE COPOLYMER VESICLES FOR PAYLOAD TRANSPORT$310,500
P20 · FY2011 · RR · contact PI
SYNTHESIS & ASSEMBLY OF BIO-RESPONSIVE COPOLYMER VESICLES FOR PAYLOAD TRANSPORT$414,646
P20 · FY2010 · RR · contact PI
Hevin Regulation of Cell Migration$44,813
F32 · FY2005 · GM